Research ArticleResearchQuality Improvement

COMFORTneo pain ratings were less consistent in extremely preterm infants

Advances in neonatal care : official journal of the National Association of Neonatal Nurses (PubMed)Jul 15, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

In 183 paired COMFORTneo assessments, overall agreement was excellent, but interrater reliability increased from 0.41 at 24 to 26 weeks' gestation to 0.92 at 36 weeks or later, indicating less consistent scoring in extremely preterm infants.

What NurseJet pulled from the source

Twenty-one NICU nurses and 12 nursing students completed paired assessments across five gestational-age groups. Overall intraclass correlation was 0.85, but agreement was much lower in infants born at 24 to 26 weeks. Body movement had the lowest item-level agreement, while respiratory response had the highest. Students had slightly higher agreement than experienced nurses, and item characteristics explained more variation than rater differences.

Why this matters for nurses

Extremely preterm infants cannot self-report pain and may display subtle or atypical behavioral cues. NICU nurses depend on consistent assessment to communicate distress, evaluate trends, and support treatment decisions, making gestational age and team calibration clinically important.

Bedside takeaway

COMFORTneo agreement was lower in extremely preterm infants, so item-level observation, team calibration, and reassessment remain important.

How This Applies in Practice

Use this when: Assessing pain or distress in a preterm infant with the COMFORTneo scale in a neonatal intensive-care setting.

On your shift

Complete each scale item as trained and document gestational age, behavioral state, respiratory support, recent procedures, medications, and other context.
Trend repeated scores and item-level observations and seek a second trained assessment when the score conflicts with the infant's clinical picture.
Use unit calibration or refresher sessions to review difficult items and scoring in extremely preterm infants.

Keep in mind: Interrater agreement does not prove diagnostic accuracy or define a treatment threshold. Follow the neonatal pain-assessment protocol, facility policy, and patient-specific provider orders.

Explain this for my unit

Key takeaways

The study analyzed 183 paired assessments by 21 NICU nurses and 12 nursing students.
Overall COMFORTneo interrater reliability was excellent at 0.85.
Reliability ranged from 0.41 at 24 to 26 weeks' gestation to 0.92 at 36 weeks or later.
Lower agreement in extremely preterm infants and variation by scale item support structured calibration and cautious interpretation.

Practice implications

Score the approved neonatal pain tool at the specified times, document contextual factors and item-level observations, and compare trends rather than relying on one number. When scores and the clinical picture conflict, repeat assessment with an experienced colleague and escalate through the neonatal pain pathway.

Limitations & cautions

This was a reliability study rather than a test of diagnostic accuracy, treatment response, or patient outcomes. The sample involved 183 paired assessments from one clinical context, subgroup sizes were unequal, and there is no objective pain reference standard, particularly for extremely preterm infants.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses (PubMed)

Advances in neonatal care : official journal of the National Association of Neonatal Nurses (PubMed). Evaluating the Interrater Reliability of the COMFORTneo Scale in Infants: Influence of Gestational Age and Rater Experience.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42485160/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Critical care nursing clinics of North America (PubMed)Jun 22, 2026Systematic ReviewPractice applicable

A clinical review describes ICU nurses as central to coordinated prevention of multidrug-resistant organism transmission through stewardship, pathogen surveillance, appropriate isolation precautions, and evidence-based hygiene practices.

ICU Med-SurgAI summaryReview source

Systematic ReviewInfection ControlWorkflowPatient EducationPractice applicableAI summary · original source linked below

The review links ICU vulnerability to immunosuppression, invasive devices, broad-spectrum antimicrobial exposure, and the care environment. It emphasizes a multimodal, team-based approach rather than a single intervention, including laboratory and antibiotic stewardship, passive and active surveillance, timely use and de-escalation of precautions, and hygiene measures. The abstract does not report a systematic search or pooled patient outcomes.

Key takeaways

Critically ill patients face overlapping exposure risks related to devices, antimicrobials, immune dysfunction, and the ICU environment.
The review frames MDRO prevention as coordinated work across bedside nursing, infection prevention, laboratory, and antimicrobial-stewardship teams.
Nursing responsibilities include surveillance, hygiene, and correct implementation and de-escalation of ordered precautions.
This is a clinical review, so it does not quantify the independent effect of any single prevention measure.

Why this matters on shift

ICU nurses are continuously positioned to recognize new transmission risks, maintain device and hygiene practices, and identify when precaution or antimicrobial plans need clarification. The review supports reliable team coordination while leaving organism-specific actions to current infection-prevention guidance.

Bedside takeaway

MDRO prevention in the ICU depends on coordinated surveillance, precautions, stewardship, hygiene, and reliable bedside execution.

Nursing implications

Verify the organism-specific precaution plan at handoff, perform the approved hygiene and device-care bundle, and communicate changes in cultures, antimicrobial therapy, or isolation status. Escalate uncertainty promptly to infection prevention and the treating team.

Limitations & cautions

The PubMed abstract describes a narrative clinical review without a reported systematic search, evidence grading, sample, or pooled effect estimates. It does not establish the comparative effectiveness of specific surveillance, isolation, stewardship, or hygiene interventions, and local resistance patterns may change implementation.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Critical care nursing clinics of North America (PubMed). Infection Prevention and Control in the Intensive Care Unit: Preventing the Spread of Multi-Drug-Resistant Organisms.

Explain this for my unit

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

European journal of psychotraumatology (PubMed)Jul 21, 2026Research ArticlePractice applicable

In a randomized trial of 55 participants age 12 to 25 with co-occurring post-traumatic stress and substance use disorders, integrated exposure-based COPE-A produced greater and faster improvement in PTSD outcomes than person-centered supportive therapy.

Psych PedsAI summaryReview source

Research ArticleResearchPatient EducationPractice applicableAI summary · original source linked below

At four months, COPE-A produced a 9.82-point greater reduction in PTSD symptom severity and lower odds of meeting PTSD diagnostic criteria than the comparison therapy; improvements were maintained through 12 months. Both groups reduced substance use and disorder severity over time, with no significant between-group difference. Participants reported greater satisfaction with COPE-A, and no study-related adverse events were reported.

Key takeaways

The trial randomized 55 adolescents and young adults age 12 to 25 to COPE-A or person-centered supportive therapy.
COPE-A produced a greater reduction in PTSD symptoms by the four-month primary endpoint.
Substance-use outcomes improved over time in both groups without a significant between-group difference.
The small single-region trial reported no study-related adverse events but cannot establish safety or effectiveness across all youth settings.

Why this matters on shift

Mental-health nurses often care for young people whose trauma symptoms and substance use interact, complicating engagement and treatment planning. The trial supports coordinated treatment rather than requiring PTSD work to wait for substance-use remission, while leaving exposure therapy to appropriately trained clinicians.

Bedside takeaway

Integrated therapy accelerated PTSD improvement, while substance-use outcomes were similar and treatment still requires trained clinical oversight.

Nursing implications

Assess and document trauma symptoms, substance use, acute risk, engagement barriers, and treatment goals without framing one condition as a reason to ignore the other. Support attendance and coping plans, monitor response and safety, and communicate changes to the clinician delivering the integrated therapy.

Limitations & cautions

The trial enrolled 55 participants in Sydney, most of whom were female, and compared two active psychotherapies. The small sample limits subgroup and uncommon-harm assessment, substance-use outcomes did not differ between groups, and results may not generalize to other ages, settings, treatment models, or levels of acuity.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

European journal of psychotraumatology (PubMed). Integrated exposure-based therapy for co-occurring post-traumatic stress and substance use among young people: a randomized controlled trial.

Explain this for my unit

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Biological research for nursing (PubMed)Jul 22, 2026Systematic ReviewPractice applicable

A meta-analysis of 22 randomized trials involving 1,396 adults in intensive care found that continuous glucose monitoring reduced hypoglycemic events and increased time in the target glucose range compared with intermittent monitoring.

ICU Med-SurgAI summaryReview source

Systematic ReviewResearchMedication SafetyPractice applicableAI summary · original source linked below

Across 22 randomized trials, continuous glucose monitoring was associated with fewer hypoglycemic events (risk ratio 0.41), 10.12 percentage points more time in the target range, lower average glucose, and less daily insulin use than intermittent monitoring. Pooled mortality was also lower, but the abstract does not report trial quality, device accuracy, care protocols, or the number of mortality events, so that estimate should not be interpreted as proof that monitoring alone improves survival.

Key takeaways

The meta-analysis included 22 randomized trials and 1,396 adult ICU patients.
Continuous monitoring was associated with fewer hypoglycemic events and 10.12 percentage points more time in the target range.
Average glucose and daily insulin use were lower with continuous monitoring.
Heterogeneity was substantial for some glycemic outcomes, and the abstract provides limited detail about device performance, trial quality, or mortality events.

Why this matters on shift

ICU nurses manage insulin infusions, recognize hypoglycemia, validate unexpected readings, and coordinate rapid treatment changes. The pooled findings support continuous monitoring as a potentially useful addition to a protocolized glycemic-safety system while leaving device selection and confirmatory-testing requirements to local policy.

Bedside takeaway

Continuous glucose monitoring improved several pooled ICU glycemic measures, but treatment-changing readings still require protocol-based validation and response.

Nursing implications

Use continuous glucose data within the approved ICU insulin protocol, review trends and alarms alongside the patient's perfusion and medication status, and confirm unexpected or treatment-changing values as required. Escalate recurrent hypoglycemia, rapidly changing readings, or discordance with the clinical picture.

Limitations & cautions

The included trials likely differed in devices, target ranges, insulin protocols, patient acuity, and confirmatory testing, and heterogeneity was substantial for average glucose and time in range. The abstract does not report risk-of-bias findings, device accuracy, adverse events, or mortality-event counts, so pooled survival results should be considered exploratory rather than causal.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Biological research for nursing (PubMed). Continuous Glucose Monitoring for Adult ICU Patients: A Meta-Analysis on Its Clinical Effectiveness.

Explain this for my unit

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

How This Applies in Practice

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

ICU review centers nurses in coordinated prevention of multidrug-resistant organism spread

Integrated exposure therapy reduced PTSD symptoms faster in young people with substance use

ICU continuous glucose monitoring reduced hypoglycemia and increased time in range across 22 trials